These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 27590706)

  • 21. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
    An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
    Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study.
    de Bruijn RF; Akoudad S; Cremers LG; Hofman A; Niessen WJ; van der Lugt A; Koudstaal PJ; Vernooij MW; Ikram MA
    J Alzheimers Dis; 2014; 42 Suppl 3():S239-49. PubMed ID: 24825566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
    Shen S; Zhou W; Chen X; Zhang J;
    Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.
    Albert M; Zhu Y; Moghekar A; Mori S; Miller MI; Soldan A; Pettigrew C; Selnes O; Li S; Wang MC
    Brain; 2018 Mar; 141(3):877-887. PubMed ID: 29365053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.
    Koch M; Fitzpatrick AL; Rapp SR; Nahin RL; Williamson JD; Lopez OL; DeKosky ST; Kuller LH; Mackey RH; Mukamal KJ; Jensen MK; Sink KM
    JAMA Netw Open; 2019 Sep; 2(9):e1910319. PubMed ID: 31560382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual Rating of Posterior Atrophy as a Marker of Progression to Dementia in Mild Cognitive Impairment Patients.
    Kim HR; Park YH; Jang JW; Park SY; Wang MJ; Baek MJ; Kim BJ; Ahn S; Kim S
    J Alzheimers Dis; 2017; 55(1):137-146. PubMed ID: 27636842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
    J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment.
    Chong MS; Tay L; Chan M; Lim WS; Ye R; Tan EK; Ding YY
    BMC Geriatr; 2015 Dec; 15():175. PubMed ID: 26715536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.